Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.46 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.46 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.46 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.46 |
| ▸ | HTR2C | P28335 | 1/20 | 0.46 |
| ▸ | HTR3A | P46098 | 1/20 | 0.46 |
| ▸ | HTR6 | P50406 | 1/20 | 0.46 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | GPR3 | P46089 | 1/20 | 0.39 |
| ▸ | EGFR | P00533 | 1/20 | 0.39 |
| ▸ | STAT3 | P40763 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12818543 | 0.84 | GPBAR1 (0.47) | MEN1KMT2A | |
| SCHEMBL27374635 | 0.83 | HTR2C (0.49) | HTR2CKDM4EGPR3EGFRSTAT3 | |
| SCHEMBL30918003 | 0.83 | HTR2C (0.49) | HTR2CKDM4EGPR3EGFRSTAT3 | |
| SCHEMBL28127943 | 0.82 | APP (0.40) | HTR2AHTR2CMAPT | |
| SCHEMBL28128276 | 0.82 | LTA4H (0.50) | L3MBTL1MEN1KMT2AKDM4EHTT | |
| SCHEMBL28206527 | 0.81 | KMT2A (0.39) | L3MBTL1MEN1KMT2ACHRM4CHRM5 | |
| SCHEMBL27372800 | 0.80 | HTR2C (0.49) | HTR2AHTR2CSTAT3HTTSMN1; SMN2 | |
| SCHEMBL31325782 | 0.80 | L3MBTL1 (0.43) | L3MBTL1MEN1KMT2ACHRM4CHRM5 | |
| SCHEMBL28127933 | 0.80 | MEN1 (0.49) | MEN1KMT2AGAAKDM4EHTT | |
| Hydrochloric Acid SCHEMBL8904172 | 0.79 | EGFR (0.49) | MEN1KMT2AGAAEGFRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4925901-A | STORAGE STAABILITY, ONIUM ION CATALYST | THE DOW CHEMICAL COMPANY (US) | 1990-05-15 | — | — | US | claimed |
| US-11731990-B2 | Carbazole-based Bodipys for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2023-08-22 | — | — | US | disclosed |
| US-11056656-B2 | Organoboron complexes and their use in organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2021-07-06 | — | — | US | disclosed |
| US-20210079024-A1 | CARBAZOLE-BASED BODIPYS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2021-03-18 | — | — | US | disclosed |
| US-20200388761-A1 | ORGANOBORON COMPLEXES FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2020-12-10 | — | — | US | disclosed |
| US-9540371-B2 | Substituted quinazolin-4(3H)-ones, pyrido[3,4-d]pyrimidin-4(3H)-ones, pyrido[3,2-d]pyrimidin-4(3H)-ones and pyrido[2,3-d]pyrimidin-4(3H)-ones as positive allosteric modulators of muscarinic acetycholine receptor M1 | VANDERBILT UNIVERSITY (US) | 2017-01-10 | — | — | US | disclosed |
| US-20160102090-A1 | SUBSTITUTED 3-BENZYLQUINOXALIN-4(3H)-ONE ANALOGS AS POSITIVE ALLOSTERIC MODULATORS OF MUSCARINIC ACETYCHOLINE RECEPTOR M1 | VANDERBILT UNIVERSITY (US) | 2016-04-14 | — | — | US | disclosed |
| WO-2014179237-A1 | SUBSTITUTED 3-BENZYLQUINOXALIN-4(3H)-ONE ANALOGS AS POSITIVE ALLOSTERIC MODULATORS OF MUSCARINIC ACETYCHOLINE RECEPTOR M1 | VANDERBILT UNIVERSITY (US) | 2014-11-06 | — | — | WO | disclosed |
| US-20100166765-A1 | BENZOQUINAZOLINE DERIVATIVES | NOVARTIS AG (CH) | 2010-07-01 | — | — | US | disclosed |
| US-20100099670-A1 | Benzoquinazoline derivatives | WIDLER LEO | 2010-04-22 | — | — | US | disclosed |
| CN-1118794-A | Latent Catalysts, Cure-inhibited epxoy resin compositions and laminates prepared therefrom | DOW CHEMICAL CO (US) | 1996-03-20 | — | — | CN | disclosed |
| CN-1118793-A | Latent catalysts, cure-inhibited epxoy resin compositions and laminates prepared therefrom | DOW CHEMICAL CO (US) | 1996-03-20 | — | — | CN | disclosed |
| EP-0553887-A2 | Catalysts and epoxy resin composition containing the same | THE DOW CHEMICAL COMPANY (US) | 1993-08-04 | — | — | EP | disclosed |
| US-5169473-A | Complex of an onium, arsenic or amine compound and boric acid; advanced polyepoxides; storage stability | THE DOW CHEMICAL COMPANY (US) | 1992-12-08 | — | — | US | disclosed |
| US-5134239-A | Quaterinary indolizine compound | THE DOW CHEMICAL COMPANY (US) | 1992-07-28 | — | — | US | disclosed |
| CN-1056699-A | Latent catalysts and cure-inhibited epoxy resin compositions and laminates made therefrom | DOW CHEMICAL CO (US) | 1991-12-04 | — | — | CN | disclosed |
| EP-0458502-A2 | Latent catalysts, cure-inhibited epoxy resin compositions and laminates prepared therefrom | THE DOW CHEMICAL COMPANY (US) | 1991-11-27 | — | — | EP | disclosed |
| US-4925901-A | STORAGE STAABILITY, ONIUM ION CATALYST | THE DOW CHEMICAL COMPANY (US) | 1990-05-15 | — | — | US | disclosed |
| EP-0328020-A2 | Use of a catalyst in epoxy compositions | THE DOW CHEMICAL COMPANY (US) | 1989-08-16 | — | — | EP | disclosed |
| EP-0204529-A2 | Anti-cancer quinazoline derivatives | BTG INTERNATIONAL LIMITED (GB) | 1986-12-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11056656-B2 | Organoboron complexes and their use in organic electroluminescent devices | NDUFC1, MT-ND6, NDUFC2 | L3MBTL1 2225/4885MEN1 1284/4885KMT2A 4143/4885 |
| US-20200388761-A1 | ORGANOBORON COMPLEXES FOR ORGANIC ELECTROLUMINESCENT DEVICES | NDUFC1, KCNC1, MT-ND6 | L3MBTL1 2264/4885MEN1 841/4885KMT2A 4071/4885 |
| US-20210079024-A1 | CARBAZOLE-BASED BODIPYS FOR ORGANIC ELECTROLUMINESCENT DEVICES | CYP1B1, ECI1, FIS1 | L3MBTL1 2498/4885MEN1 1888/4885KMT2A 3625/4885 |
| US-20100166765-A1 | BENZOQUINAZOLINE DERIVATIVES | CACNA1A, BMP4, TPX2 | L3MBTL1 1697/4885MEN1 904/4885KMT2A 2241/4885 |
| US-20100099670-A1 | Benzoquinazoline derivatives | ABCG2, UGT2B7, CYP3A7 | L3MBTL1 3535/4885MEN1 1670/4885KMT2A 1474/4885 |
| US-20160102090-A1 | SUBSTITUTED 3-BENZYLQUINOXALIN-4(3H)-ONE ANALOGS AS POSITIVE ALLOSTERIC MODULATORS OF MUSCARINIC ACETYCHOLINE RECEPTOR M1 | CHRM1, CHRM3, CHRM4 | L3MBTL1 2067/4885MEN1 1890/4885KMT2A 961/4885 |
| US-11731990-B2 | Carbazole-based Bodipys for organic electroluminescent devices | CYP1B1, ECI1, FIS1 | L3MBTL1 2498/4885MEN1 1888/4885KMT2A 3625/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.